Publication
CIPO patent filing trends 2024 and forward-looking commentary
CIPO released a 2024 report showing a decrease of approximately 6% in overall patent applications filed into Canada
2022 Guide to Canada’s Pharmaceutical Intellectual Property Regime
Canada | Publication | July 2022
Our 2022 Guide to Canada’s Pharmaceutical Intellectual Property Regime is a convenient all-in-one reference to the important legal and regulatory regimes governing pharmaceuticals in Canada.
The Guide provides a detailed review of the key regimes, including:
- Data protection market exclusivity;
- The Patented Medicines (Notice of Compliance) Regulations (PMNOC), linking generic market access to patent rights;
- Certificate of Supplementary Protection (CSP) exclusivity;
- Biologics; and
- Drug pricing and market access.
We are honoured that the Guide includes a Foreword by our partner, The Right Honourable Brian Mulroney. During his tenure as the 18th Prime Minister of Canada, Mr. Mulroney championed a series of significant legislative reforms to improve protections for pharmaceuticals that continue to operate today. The COVID-19 pandemic has highlighted the importance of fostering investment in research, development and manufacturing by the innovative pharmaceutical industry in Canada. Norton Rose Fulbright’s pharmaceuticals and life sciences team understands the innovative pharmaceutical industry and will continue to work with innovators to defend their rights and maintain the benefits they bring to all Canadians.
We hope this Guide will assist in navigating the complex challenges of this rapidly evolving field.
Recent publications
Publication
CSA proposes new “access equals delivery” model for financial statements and accompanying MD&A
Recognizing securityholders’ increased use of electronic means to access financial information of reporting issuers, the CSA is proposing the expansion of its “access equals delivery” model to allow reporting issuers to deliver such information by giving notice to securityholders that such information may be accessed electronically.
Publication
A look at the actions taken in the first year of Canada’s modern slavery legislation
Under Canada’s new modern slavery legislation, the Fighting Against Forced Labour and Child Labour in Supply Chains Act, applicable entities must file a report by May 31 each year describing the risks of forced labour and child labour in their business and supply chains and steps taken to address those risks.
Subscribe and stay up to date with the latest legal news, information and events . . .